Vazegepant hydrochloride
Product Specifications
CAS Number
1414976-20-7
Target
CGRP Receptor
Related Pathways
Neuroscience, GPCR/G Protein
Purity
0.9956
Bioactivity
Vazegepant hydrochloride (Vazegepant HCl) is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
Smiles
Cl.CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](Cc1cc(C)c2[nH]ncc2c1)NC(=O)N1CCC(CC1)c1cc2ccccc2[nH]c1=O
Molecular Formula
C36H47ClN8O3
Molecular Weight
675.3
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
#29045-500uL 1x 500 µL
Annexin V, R-phycoerythrin Conjugate (100 assays)
Sign In for Pricing
View Details 
AP51769PU-N 400 µL
POC1B-GALNT4 (N-term) Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
